KOSMOS-II: KPMNG Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II (clinicaltrials.gov) - Oct 1, 2026 - P=N/A | N=1000 | Active, not recruiting | Sponsor: Seoul National University Bundang Hospital | Recruiting ➔ Active, not recruiting | Trial primary completion date: Sep 2026 ➔ Mar 2027
Enrollment closed • Trial primary completion date • Tumor mutational burden • Oncology • Solid Tumor
|